108 related articles for article (PubMed ID: 21780344)
41. Management of treatment-refractory obsessive compulsive disorder patients.
Dominguez RA; Mestre SM
J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
[TBL] [Abstract][Full Text] [Related]
42. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report.
Angelucci F; Ricci V; Martinotti G; Caltagirone C; Bria P
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1277-8. PubMed ID: 19555731
[No Abstract] [Full Text] [Related]
43. Prozac for pediatric use.
FDA Consum; 2003; 37(2):3. PubMed ID: 12715749
[No Abstract] [Full Text] [Related]
44. Treatment of Raynaud's phenomenon with escitalopram.
Buecking A; Rougemont E; Fabio Zullino D
Int J Neuropsychopharmacol; 2005 Jun; 8(2):307-8. PubMed ID: 15569398
[No Abstract] [Full Text] [Related]
45. [Schizophrenic with obsessive-compulsive disorder or symptoms].
Doubremelle C; Millet B; Olie JP
Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
[TBL] [Abstract][Full Text] [Related]
46. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
Fontenelle LF; Mendlowicz MV; Versiani M
Psychol Med; 2004 Jan; 34(1):181; author reply 181-3. PubMed ID: 14971639
[No Abstract] [Full Text] [Related]
47. Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Kar SK; Srivastava A
Asian J Psychiatr; 2017 Dec; 30():44-46. PubMed ID: 28738260
[No Abstract] [Full Text] [Related]
48. Early-onset schizophrenia and obsessive-compulsive disorder in a young man with Dandy-Walker variant.
Papazisis G; Mastrogianni A; Karastergiou A
Schizophr Res; 2007 Jul; 93(1-3):403-5. PubMed ID: 17478081
[No Abstract] [Full Text] [Related]
49. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
50. Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study.
Lee EY; Park JK; Lee W; Kim YK; Park CS; Giles JT; Park JW; Shin K; Lee JS; Song YW; Lee EB
Rheumatology (Oxford); 2014 Apr; 53(4):658-64. PubMed ID: 24352340
[TBL] [Abstract][Full Text] [Related]
51. Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder.
Alessi N; Bos T
Am J Psychiatry; 1991 Nov; 148(11):1605-6. PubMed ID: 1928487
[No Abstract] [Full Text] [Related]
52. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
Go FS; Malley EE; Birmaher B; Rosenberg DR
J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
[TBL] [Abstract][Full Text] [Related]
53. Paroxysmal Perceptual Alteration: Drug-Induced Phenomenon or Schizophrenic Psychopathology?
Praharaj SK; Kongasseri S; Acharya M
Am J Ther; 2016; 23(2):e628-30. PubMed ID: 26954463
[TBL] [Abstract][Full Text] [Related]
54. Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.
Safranko I
Aust N Z J Psychiatry; 2003 Feb; 37(1):112. PubMed ID: 12534671
[No Abstract] [Full Text] [Related]
55. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
[No Abstract] [Full Text] [Related]
56. Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazole.
Peters B; de Haan L
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1576-7. PubMed ID: 19766686
[No Abstract] [Full Text] [Related]
57. [Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
Bellino S; Barzega G; Bogetto F; Maina G; Ravizza L
Minerva Psichiatr; 1995 Mar; 36(1):47-50. PubMed ID: 7643732
[No Abstract] [Full Text] [Related]
58. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
Margetić B; Aukst-Margetić B; Jakovljević M
Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
[No Abstract] [Full Text] [Related]
59. An uncommon case of hypersexual behaviour with frotteurism.
Bhatia MS; Jhanjee A; Srivastava S; Kumar P
Med Sci Law; 2010 Oct; 50(4):228-9. PubMed ID: 21539293
[TBL] [Abstract][Full Text] [Related]
60. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
